Thousands to get cutting-edge personalised cancer vaccines in NHS trials
The latest vaccine technology is being used to create personalised treatments that target the DNA of patients' specific tumours.
Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The latest vaccine technology is being used to create personalised treatments that target the DNA of patients' specific tumours.
A man with bowel cancer has become the first person in England to be treated with a personalised jab for the disease on the NHS.
A man with bowel cancer has become the first of thousands to be treated with a personalised jab as part of the NHS Cancer Vaccine Launch Pad.
Clinicians look for specific mutations in a patient's tumour and create a personalised treatment designed to stimulate the immune system after surgery to remove tumours so it can recognise and attack any remaining cancer cells.
Although questions remain about ideal treatment strategies, consistent data have shown that patients should be treated early.